Median OS was not significantly different among patients with monoallelic TP53‐mutant MDS, multihit TP53‐mutant MDS, and monoallelic TP53‐mutant AML (median OS: 439 days vs. 376 days vs. 439 days, respectively) (Figure 3A). This evidence concerns the gene TP53 and acute myeloid leukemia.